Zhejiang Garden Biopharmaceutical: Zhejiang Garden Biopharmaceutical Co., Ltd.'s entrusted management report for the issuance of convertible corporate bonds to unspecified targets (2023).

SZSI · Jun 28

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.